Results 11 to 20 of about 275,085 (309)

Therapeutic Plasma Exchange: For Cancer Patients

open access: yesCancer Management and Research, 2022
Yuru Hu, Hanshan Yang, Shaozhi Fu, Jingbo Wu Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People’s Republic of ChinaCorrespondence: Jingbo Wu; Shaozhi FuDepartment of Oncology, The Affiliated Hospital ...
Hu Y, Yang H, Fu S, Wu J
doaj   +2 more sources

In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange? [PDF]

open access: yesHematology, Transfusion and Cell Therapy
Background: In patients with suspected immune thrombotic thrombocytopenic purpura, guidelines suggest that therapeutic plasma exchange should be initiated within eight hours. However, this time threshold may be difficult to attain.
Alexandre Soares Ferreira Junior   +7 more
doaj   +2 more sources

Safety and Efficacy of Therapeutic Plasma Exchange in Pediatric Non-Neurological Diseases. [PDF]

open access: yesInt J Nephrol Renovasc Dis
Monika Miklaszewska,1,2 Magdalena Błasiak,2,3 Przemysław Korohoda,4 Ewelina Jarosz-Wójcik,1,2 Katarzyna Zachwieja,1,2 Karina Madej-Świątkowska,2,3 Dorota Drożdż1,2 1Department of Pediatric ...
Miklaszewska M   +6 more
europepmc   +2 more sources

Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience

open access: yesCritical Care Explorations, 2021
IMPORTANCE:. Recent evidence suggests a multilevel inflammatory syndrome as a driving factor in some of the most severely ill coronavirus disease 2019 patients with overlapping features to other hyperinflammatory or autoimmune diseases. Therefore, plasma
Christian Nusshag, MD   +9 more
doaj   +1 more source

Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database. [PDF]

open access: yesPLoS ONE, 2018
Secondary pulmonary hemorrhage increases the risk of mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV); plasma exchange therapy may improve outcomes in these patients.
Eishi Uechi   +2 more
doaj   +1 more source

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary

open access: yesKidney Medicine, 2023
Rationale & Objective: We sought to elicit patient preferences regarding the use of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and its tradeoffs of risk of kidney failure and risk of serious infection.
David Collister   +15 more
doaj   +1 more source

Plasma-enhanced microbial electrolytic disinfection: Decoupling electro- and plasma-chemistry in plasma-electrolyzed oxidizing water using ion-exchange membranes

open access: yes, 2022
Pathogenic microorganisms pose a global threat to public health and environment. Common antibacterial chemicals produce toxic residues, inevitably harming the environment.
Guo, Li   +7 more
core   +1 more source

Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome

open access: yesFrontiers in Immunology, 2023
Plasma exchange rapidly depletes pathogenic anti-neutrophil cytoplasmic autoantibodies (ANCAs) and is considered for induction therapy in severe ANCA-associated vasculitis.
Ann-Kathrin Schäfer   +5 more
doaj   +1 more source

Plasma-Assisted Synthesis of Metal Nitrides for an Efficient Platinum-Group-Metal-Free Anion-Exchange-Membrane Fuel Cell

open access: yes, 2022
In comparison to the well-developed proton-exchange-membrane fuel cells, anion-exchange-membrane fuel cells (AEMFCs) permit adoption of platinum-group-metal (PGM)-free catalysts due to the alkaline environment, giving a substantial cost reduction ...
Min-Rui Gao (1440532)   +11 more
core   +1 more source

Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation

open access: yesRenal Replacement Therapy, 2017
Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the treatment is
Yusuke Kaida   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy